Identification of activated matrix metalloproteinase‐2 (MMP‐2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography
- 12 March 2002
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 197 (2) , 179-187
- https://doi.org/10.1002/path.1080
Abstract
The involvement of extracellular matrix-degrading enzymes, such as matrix metalloproteinases and serine proteases, during tumour progression and metastasis is well established. In particular, the activation of pro-matrix metalloproteinase (MMP)-2 on the surface of malignant cells by membrane-bound MT1-MMP has been shown to contribute to the invasive abilities of various tumours. This study presents evidence that in tissue of malignant melanomas, increased effective gelatinolytic activity is mainly located at sites where melanoma cells interact with the surrounding extracellular matrix. Forty-one primary melanomas (30 superficial spreading and 11 nodular type) and six lymph node metastases were investigated by a modified technique of gelatin in situ zymography. This technique localizes areas of effective proteolytic activity within tissue sections. In 28/41 (68%) primary melanomas and in 6/6 (100%) metastases, considerable proteolysis was detected at the invading part of the tumour and especially at sites of tumour–stroma interactions, whereas no or only weak proteolytic activity was localized within the centres of solid nests of tumour cells. Zymographic analysis of extracts obtained from different areas of microdissected melanoma specimens identified activated MMP-2 as the enzyme responsible for this activity. Immunohistochemical analysis detected strong staining for MMP-2 and MT1-MMP, even in areas in which no proteolytic activity was found by in situ zymography, emphasizing the importance of more functional techniques for the investigation of balanced proteolytic systems. This technology makes it possible to draw conclusions regarding the balance between activated proteases and inhibitors, which are frequently found to be present together in close proximity in vivo. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 27 references indexed in Scilit:
- Matrix metalloproteinases in angiogenesis: a moving target for therapeutic interventionJournal of Clinical Investigation, 1999
- Tissue inhibitors of metalloproteinases (TEMP) in invasion and proliferationAPMIS, 1999
- Trendsin Molecular Medicine: Matrix metalloproteinases and their inhibitors in tumour growth and invasionAnnals of Medicine, 1999
- The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase AJournal of Biological Chemistry, 1998
- Molecular regulation of cellular invasion— role of gelatinase A and TIMP-2Biochemistry and Cell Biology, 1996
- Proteolytic remodeling of extracellular matrixCurrent Opinion in Cell Biology, 1995
- Fibroblast-dependent tumorigenicity of melanoma xenografts in athymic miceInternational Journal of Cancer, 1992
- Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils.The Journal of cell biology, 1991
- Modulation of type‐iv collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type‐iv collagenaseInternational Journal of Cancer, 1990
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984